33 related articles for article (PubMed ID: 38635255)
1. Rituximab alleviates pediatric systemic lupus erythematosus associated refractory immune thrombocytopenia: a case-based review.
Mu F; Bai X; Lou Y; Luo P; Guo Q
Immunol Res; 2024 Jan; ():. PubMed ID: 38279058
[TBL] [Abstract][Full Text] [Related]
2. Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE-related immune thrombocytopenia.
Brik-Simon D; Efros O; Levinsky Y; Amarilyo G; Tirosh I; Levy-Mendelovich S; Steinberg-Shemer O; Izraeli S; Yacobovich J; Gilad O
Pediatr Blood Cancer; 2024 May; 71(5):e30911. PubMed ID: 38348516
[TBL] [Abstract][Full Text] [Related]
3. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
[TBL] [Abstract][Full Text] [Related]
4. Lupus anticoagulant in immune thrombocytopenic purpura.
Dash S; Marwaha RK; Mohanty S
Indian J Pediatr; 2004 Jun; 71(6):505-7. PubMed ID: 15226559
[TBL] [Abstract][Full Text] [Related]
5. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
6. Which pediatric ITP patients will go on to lupus?
Neufeld EJ
Blood; 2024 Apr; 143(16):1553-1554. PubMed ID: 38635255
[No Abstract] [Full Text] [Related]
7. Immune thrombocytopenia and COVID-19: Case report and review of literature.
Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for children with immune thrombocytopenia: a systematic review.
Liang Y; Zhang L; Gao J; Hu D; Ai Y
PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
[TBL] [Abstract][Full Text] [Related]
9. Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.
Bashyal KP; Shah S; Ghimire C; Balmuri S; Chaudhary P; Karki S; Poudel AK; Pokharel A; Devarkonda V; Hayat S
Int J Rheumatol; 2024; 2024():6650921. PubMed ID: 38464849
[TBL] [Abstract][Full Text] [Related]
10. Update on the Intercontinental Cooperative ITP Study Group (ICIS) and on the Pediatric and Adult Registry on Chronic ITP (PARC ITP).
Kühne T
Pediatr Blood Cancer; 2013; 60 Suppl 1():S15-8. PubMed ID: 23109493
[TBL] [Abstract][Full Text] [Related]
11. Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia.
Garzon AM; Mitchell WB
Front Pediatr; 2015; 3():70. PubMed ID: 26322297
[TBL] [Abstract][Full Text] [Related]
12. The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature.
Mohammadpour F; Kargar M; Hadjibabaie M
J Res Pharm Pract; 2018; 7(1):4-12. PubMed ID: 29755993
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
